Aptevo Therapeutics Inc. Annual Earnings Per Share, Basic in USD/shares from 2021 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Aptevo Therapeutics Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2021 to 2023.
  • Aptevo Therapeutics Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.48 USD/shares, a 97.8% increase year-over-year.
  • Aptevo Therapeutics Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was 45.2 USD/shares.
  • Aptevo Therapeutics Inc. annual Earnings Per Share, Basic for 2023 was -1.42 USD/shares, a 190% decline from 2022.
  • Aptevo Therapeutics Inc. annual Earnings Per Share, Basic for 2022 was 1.57 USD/shares.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1 -$3 -190% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $1.57 +$7.64 Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 -$6 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.